66 research outputs found

    Influence of the Surface Layer when the CMT Process Is Used for Welding Steel Sheets Treated by Nitrooxidation

    Get PDF
    Nitrooxidation is a non-conventional surface treatment method that can provide significantly improved mechanical properties as well as corrosion resistance. However, the surface layer is a major problem during the welding process, and welding specialists face many problems regarding the weldability of steel sheets. This paper deals with the properties of a nitrooxidized surface layer, and evaluates ways of welding steel sheets treated by nitrooxidation using a Cold Metal Transfer (CMT) process. The limited heat input and the controlled metal transfer, which are considered as the main advantage of the CMT process, have a negative impact on weld joint quality. An excessive amount of porosity is observed,probably due to the high content of nitrogen and oxygen in the surface layer of the material and the fast cooling rate of the weld pool

    Three-Dimensional two-pion source image from Pb+Pb Collisions at Sqrts_NN=17.3 GeV: New constraints for source breakup dynamics

    Get PDF
    Source imaging methodology is used to provide a three-dimensional two-pion source function for mid-rapidity pion pairs with pT<70p_T<70 MeV/c in central (070-7%) Pb+Pb collisions at sNN\sqrt s_{NN}=17.3 GeV. Prominent non-Gaussian tails are observed in the pion pair transverse momentum (outward) and in the beam (longitudinal) directions. Model calculations reproduce them with the assumption of Bjorken longitudinal boost invariance and transverse flow blast-wave dynamics coupled with "outside-in burning" in the transverse direction; they also yield a proper time for breakup and emission duration for the pion source.Comment: Six pages 4 figs. Submitted for publicatio

    Reconciling the professional and student identities of clinical psychology trainees

    Get PDF
    The study explored the ways in which qualified and trainee clinical psychologists perceived professional behaviour, as illustrated in a series of short vignettes, in student and clinical practice contexts. Comparisons were made to identify the extent to which ideas of professionalism differed across different learning contexts and between qualified and unqualified staff, with the aim of adding to the literature on which factors influence the development of professional identity in health professionals. An online questionnaire depicting a range of potentially unprofessional behaviours was completed by 265 clinical psychology trainees and 106 qualified clinical psychologists. The data were analysed using a general linear model with simultaneous entry in which rater (trainee vs qualified clinical psychologist), setting (student vs placement) and their interaction predicted acceptability ratings. We found that, in general, trainees and qualified staff agreed on those behaviours that were potentially unprofessional, although where significant differences were found, these were due to trainees rating the same behaviours as more professionally acceptable than qualified clinical psychologists. Despite trainees identifying a range of behaviours as professionally unacceptable, some percentage reported having engaged in a similar behaviour in the past. Irrespective of the status of the rater, the same behaviours tended to be viewed as more professionally unacceptable when in a placement (clinical) setting than in a student (university) setting. Generally, no support was found for a rater by setting interaction. The study suggests that trainee clinical psychologists are generally successful at identifying professional norms, although they do not always act in accordance with these. Conflicting student and professional norms may result in trainees viewing some potentially unprofessional behaviour as less severe than qualified staff. Health professional educators should be aware of this fact and take steps to shape trainee norms to be consistent with that of the professional group

    Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Get PDF
    Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome

    Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Get PDF
    Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome

    Tribological Behaviour of Smart Fluids Influenced by Magnetic and Electric Field – A Review

    No full text
    This review paper highlights the tribological behaviour and performance of smart fluids. Two main kinds of smart fluids, that respond to a suitable external stimulus are investigated – electrorheological and magnetorheological fluid. The excitation of an external active field significantly increases or decreases the fluidity, depending on the fluid type. First, the tribological behaviour of both types of smart fluids without the influence of an external field and under the external active field, respectively, are reviewed. Subsequently, the influence of external field activation on the lubricating layer is described. Finally, a summary of the most notable findings of investigated smart fluids performance and behaviour is provided. Possible future applications are then considered for smart lubricants technology and engineering devices
    corecore